Rab 37 inhibitors are chemical compounds that specifically target and modulate the activity of the Rab 37 protein, a member of the Rab family of small GTPases. Rab proteins are crucial for intracellular vesicle trafficking, and Rab 37, in particular, plays a significant role in the regulation of vesicle transport in the secretory pathway. As a GTPase, Ra b37 alternates between an active GTP-bound state and an inactive GDP-bound state, regulating the docking and fusion of vesicles to specific target membranes. Inhibitors of Rab 37 are designed to disrupt this cycle, either by interfering with GTP binding, hydrolysis, or the interaction with effector proteins. By blocking Rab 37's activity, these inhibitors can alter vesicular trafficking dynamics, affecting processes such as exocytosis, endocytosis, and the transport of proteins or other cellular components. The disruption of Rab 37's function can have downstream effects on the organization and dynamics of cellular compartments like the Golgi apparatus, endosomes, and the plasma membrane.
Structurally, Rab 37 inhibitors are diverse, and their design often depends on the mechanism through which they aim to block Rab 37 function. Some may act as competitive antagonists at the nucleotide binding site, while others may hinder the interaction between Rab 37 and its guanine nucleotide exchange factors (GEFs), GTPase-activating proteins (GAPs), or effector molecules. These inhibitors can vary greatly in their chemical properties, including size, polarity, and lipophilicity, which affect their ability to access intracellular compartments and bind to Rab 37 effectively. The study of Rab 37 inhibitors provides insight into the fundamental cellular processes governed by vesicle trafficking and helps in understanding the broader regulation of membrane dynamics. By manipulating the activity of Rab 37, researchers can uncover the specific pathways and molecular mechanisms in which this GTPase is involved, leading to a deeper understanding of vesicular transport and cellular organization.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine can inhibit DNA methyltransferase, potentially leading to changes in gene expression patterns. Hypothetically, this could affect the expression of Ras-related protein Rab-37. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor. By affecting chromatin structure, it could modulate the transcriptional activity of the Rab-37 gene. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic Acid, another histone deacetylase inhibitor, can impact gene expression patterns by influencing chromatin remodeling. This may potentially alter Rab-37 protein expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Mithramycin A binds to GC-rich DNA regions, possibly inhibiting the binding of certain transcription factors. This could affect the expression of Rab-37 if its promoter has such sequences. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D binds to DNA, preventing RNA synthesis. If applied in the right context, it could inhibit Rab-37 mRNA transcription. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $42.00 $185.00 $310.00 $650.00 | 6 | |
DRB inhibits RNA polymerase II, which is essential for mRNA synthesis. This could result in decreased Rab-37 mRNA levels. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
Quercetin can modulate the activity of various transcription factors. If any of these factors are involved in Rab-37 expression, Quercetin might influence its levels. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein inhibits tyrosine kinases, which are part of various signaling pathways. It could impact Rab-37 expression if related pathways are involved. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin inhibits PI3K, a kinase involved in several cellular processes. If PI3K pathways influence Rab-37 expression, this compound might be relevant. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 inhibits MEK, which is a part of the MAPK pathway. If the MAPK pathway affects Rab-37 expression, this compound could play a role. | ||||||